Pages that link to "Q35072182"

The following pages link to Asian-Pacific consensus statement on the management of chronic hepatitis B: an update (Q35072182):

Displaying 48 items.

• Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection (Q24197858) (← links)
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases (Q24243006) (← links)
• Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases (Q24244017) (← links)
• Current antiviral therapy for chronic hepatitis B. (Q33631693) (← links)
• Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive. (Q34017787) (← links)
• A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B. (Q34604857) (← links)
• Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis (Q34615975) (← links)
• Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study (Q34735876) (← links)
• Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications (Q35597930) (← links)
• Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics (Q35615890) (← links)
• The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis (Q35726960) (← links)
• Cancer screening practices of Asian American physicians in New York City (Q35857543) (← links)
• Practical difficulties in the management of hepatitis B in the Asia-Pacific region (Q35860206) (← links)
• Lamivudine for chronic hepatitis B. (Q35917357) (← links)
• Preventing and treating hepatitis B infection (Q38630524) (← links)
• Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B. (Q35951737) (← links)
• Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B. (Q36120804) (← links)
• Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update (Q36135493) (← links)
• Peginterferon-alpha 2a for the treatment of hepatitis B infection (Q36192764) (← links)
• Predicting survival in hepatitis B. (Q36287863) (← links)
• Therapeutic implications of hepatitis B virus genotypes. (Q36338675) (← links)
• Management of chronic hepatitis B virus infection: a new era of disease control (Q36393856) (← links)
• Personal view: the management of chronic hepatitis B infection (Q36435893) (← links)
• Chronic hepatitis B--who should be treated? (Q36568440) (← links)
• Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection. (Q36642950) (← links)
• Management of patients with HBeAg-negative chronic hepatitis B (Q36724421) (← links)
• Telbivudine: a new option for the treatment of chronic hepatitis B. (Q36810314) (← links)
• Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence (Q36918239) (← links)
• Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state". (Q37278066) (← links)
• Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment (Q37343288) (← links)
• Chronic hepatitis B in Asia—new insights from the past decade (Q37825657) (← links)
• Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly (Q39954863) (← links)
• Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative (Q40400198) (← links)
• Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. (Q42181000) (← links)
• Anti-HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis (Q42261578) (← links)
• Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirin (Q42948075) (← links)
• A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection. (Q45045460) (← links)
• Thymalfasin for the treatment of chronic hepatitis B. (Q45105046) (← links)
• Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. (Q45105367) (← links)
• New targets and inhibitors of HBV replication to combat drug resistance (Q45130525) (← links)
• Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine. (Q45403562) (← links)
• A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin (Q45424198) (← links)
• Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy. (Q46841533) (← links)
• Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. (Q53179615) (← links)
• Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma (Q57469823) (← links)
• Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha (Q58376712) (← links)
• Historia natural y manifestaciones clínicas de la hepatitis B crónica (Q61770450) (← links)
• Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B (Q83155240) (← links)